Director Gary S. Roubin filed a Form 4 with the SEC on November 17, 2026, disclosing the purchase of 153,846 shares of InspireMD, Inc. common stock on November 13, 2026, as part of the company's underwritten public offering.

Key Highlights

  • Purchase date: Gary S. Roubin acquired 153,846 shares of common stock on November 13, 2026.
  • Price per unit: The combined public offering price was $0.65 per share of common stock and accompanying Series L common stock warrants.
  • Resulting ownership: Following the transaction, Roubin directly holds 988,324 shares of common stock.
  • Warrant acquired: Roubin also acquired a Series L common stock warrant for 115,385 shares, exercisable at $0.65 per share.
  • Warrant term: The Series L warrants are immediately exercisable and expire on November 16, 2027, according to the filing.
  • Transaction code: The filing records both the common stock purchase and the warrant acquisition under transaction code P (open market or private purchase).

Roubin Participates in InspireMD Public Offering, Adding Shares and Warrants

According to the Form 4 filing, Gary S. Roubin, a director of InspireMD, Inc. (NASDAQ:NSPR), purchased 153,846 shares of common stock on November 13, 2026, at a combined public offering price of $0.65 per share. The filing states that these shares were purchased "in the Issuer's underwritten public offering at a combined public offering price of $0.65 per share of common stock and accompanying Series L common stock warrants." Following this acquisition, the filing reports Roubin's direct beneficial ownership at 988,324 shares of common stock.

In addition to the common stock purchase, the filing discloses that Roubin acquired a Series L common stock warrant on the same date, covering 115,385 shares of common stock. The warrant was acquired at a price of $0.00 and carries an exercise price of $0.65 per share. The filing notes that these warrants are "immediately exercisable" and have an expiration date of November 16, 2027. Following the transaction, Roubin directly holds 115,385 Series L warrants.

The form was signed by Michael Lawless as Attorney-in-Fact for Gary S. Roubin and filed on November 17, 2026. The filing was made pursuant to Section 16(a) of the Securities Exchange Act of 1934 and covers transactions by one reporting person. No amendment date is indicated, suggesting this is an original filing.

What Was Disclosed

Director Gary S. Roubin reported the purchase of 153,846 shares of InspireMD common stock and 115,385 Series L warrants on November 13, 2026, through the company's underwritten public offering, bringing his direct share ownership to 988,324 shares.